Overview
- Rocket Lab announced the roughly $8 billion cash‑and‑stock deal for Iridium on June 29, with Iridium shareholders to receive $54 per share and the companies targeting a close around mid‑2027 pending shareholder and regulatory approval.
- The acquisition would add Iridium’s 66‑satellite low‑Earth‑orbit constellation, control of global L‑band spectrum and roughly 2.5 million subscribers, which Rocket Lab says will provide predictable, recurring revenue beyond launch and manufacturing contracts.
- To fund the transaction Rocket Lab has lined up mixed financing that includes a reported $3.6 billion, 364‑day senior secured bridge loan plus planned debt and equity, and the company also has an open $3 billion at‑the‑market equity program that has raised investor dilution concerns.
- Shareholders reacted with sharp selling in early July as market volatility, a newly filed securities class action over Neutron timeline disclosures and CEO Peter Beck’s disclosed sale of 5 million shares intensified scrutiny of Rocket Lab’s near‑term plans.
- Analysts offered divergent views: some raised bullish long‑term targets citing the integrated strategy and Iridium’s cash flows, but investors are watching two clear near‑term gates — financing clarity and the successful development and first launch of the Neutron rocket — to judge whether the deal will pay off.